EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RASSF1A: Not a prototypical Ras effector



RASSF1A: Not a prototypical Ras effector



Small Gtpases 2(3): 148-157



The Ras association domain family (RASSF) of genes are commonly silenced by promoter specific methylation in human cancers. After the cloning of the first two family members in early 2000 (RASSF1 and RASSF5), eight other related genes have been identified (RASSF2, 3, 4 and 6-10). The unifying motif amongst all RASSF family members is the presence of the Ras association (RA) domain that could potentially associate with the Ras family of GTPases. Detailed analyses have determined that RASSF family members are tumor suppressor proteins, activators of cell death, cell cycle modulators, microtubule stabilizers and possibly inflammatory mediators linked to NFκB. As such, exploring the biological function of this gene family is needed and if indeed RASSF proteins could be the missing link between Ras signaling and apoptosis. Several RASSF family members have been demonstrated to associate with Ras. However, there is still controversy regarding the ability of RASSF1A to utilize Ras to promote cell death and of the importance of the RASSF1A RA domain. The focus of this review is to highlight the importance of Ras binding to the RASSF family of proteins and discuss what we currently know about the biology of RASSF1A.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333498

Download citation: RISBibTeXText

PMID: 21776416

DOI: 10.4161/sgtp.2.3.16286



Related references

When RASSF1A RAN into tumor suppression: Ran GTPase is a RASSF1A effector involved in controlling microtubule organization. Cell Cycle 8(23): 3796-3797, 2010

The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A. Protein & Cell 2(3): 237-249, 2011

RAN GTPase is a RASSF1A effector involved in controlling microtubule organization. Current Biology 19(14): 1227-1232, 2009

Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions. Journal of Biological Chemistry 286(21): 18483-18491, 2011

The representation of prototypical and non-prototypical vowels in peri-sylvian cortical areas. Society for Neuroscience Abstracts 26(1-2): Abstract No -737 14, 2000

Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor. Journal of Huazhong University of Science and Technology. Medical Sciences 28(2): 182-184, 2008

The influence of promoter methylation of RASSF1A on RASSF1A mRNA and protein expression in gastric cancer tissues. Zhonghua Nei Ke Za Zhi 45(12): 1008-1012, 2007

Protein kinase A-mediated phosphorylation of the RASSF1A tumour suppressor at Serine 203 and regulation of RASSF1A function. European Journal of Cancer 46(16): 2986-2995, 2011

The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. Journal of Biological Chemistry 279(28): 29247-29254, 2004

The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. Plos Genetics 9(8): E1003705-E1003705, 2014

Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Current Allergy and Asthma Reports 3(1): 86-93, 2003

Use of Ras effector RASSF1A promoter gene methylation and chromosome 9p loss of heterozygosity (LOH) to predict progression-free survival (PFS) in perioperative chemotherapy (CT) phase III trial IFCT-0002 in resectable non-small cell lung cancer. Journal of Clinical Oncology 26(15_suppl): 7500-7500, 2016

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. Bmc Cancer 12: 243-243, 2013

The effect of similarity between the study and the prototypical exemplars on the recognition of prototypical exemplars. Shinrigaku Kenkyu 61(4): 273-277, 1990

The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles. Journal of Biological Chemistry 280(5): 3920-3927, 2004